Risk perception and reasons for noncompliance in pharmacovigilance: A qualitative study conducted in Canada

Drug Safety

Volumn 32, Issue 7, 2009, Pages 579-590

  Nichols, Vincent ^a   Thériault Dubé, Isabelle ^a   Touzin, Julie ^a,c   Delisle, Jean François ^a   Lebel, Denis ^a   Bussières, Jean François ^a   Bailey, Benoît ^a   Collin, Johanne ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Pharmacy Department   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CLINICAL PRACTICE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; MALE; NORMAL HUMAN; PERCEPTION; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RISK; VOLUNTARY REPORTING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; CANADA; DATA COLLECTION; FEMALE; FOCUS GROUPS; GUIDELINE ADHERENCE; HUMANS; MALE; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHYSICIANS; PROFESSIONAL ROLE; RISK;

EID: 67649286666     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/00002018-200932070-00004     Document Type: Article

References (46)

1. Lexchin J. Drug withdrawals from the Canadian market for safety reasons 1963-2004. CMAJ 2005; 172 (6): 765-7
2. Alvarez-Requejo A, Cranajal A, Be' gaud B, et al. Underresponding of adverse drug reactions. Eur J Clin Pharmacol 1998; 54: 483-8
3. Be' gaud B, Martin K, Haramburu F, et al. Rates of spontaneous reporting of adverse reactions in France [letter]. JAMA 2002; 288 (13): 1588
4. Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review.Drug Saf 2006; 29 (5): 385-96
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279 (15): 1200-5
6. Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77-83
7. Moride Y, Haramburu F, Requejo A, et al. Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol 1997; 43: 177-81
8. Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999; 88: 965-8
9. Haffner S, Von Laue N, Wirth S, et al. Detecting adverse drug reactions on paediatric wards. Drug Saf 2005; 28 (5): 453-64
10. Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in pediatric outpatients. Br J Clin Pharmacol 2002; 54: 665-70
11. Turner S, Longworth A, Nunn AJ, et al. Unlicensed and off-label drug use in paediatric wards: prospective study. Br Med J 1998; 316: 343-5
12. Jong GW, Vulto AG, de Hoog M, et al. Survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics 2001; 108: 1089-93
13. McIntyre J, Conroy S, Avery A, et al. Unlicensed and off-label prescribing of drugs in general practice. Arch Dis Child 2000; 83: 498-501
14. Chalumeau M, Treluyer JM, Salanave B, et al. Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child 2000; 83: 502-5
15. Belton KJ, Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Group. Eur J Clin Pharmacol 1997; 52: 423-7
16. Thiessard F, Roux E, Miremond-Salame G, et al. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf 2005; 28 (8): 731-40
17. Bä ckström M, Mjö rndal T, Dahlqvist R. Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol 2000; 56: 729-32
18. Strom Brai L. Potential for conflict of interest in the evaluation of suspected adverse drug reactions. JAMA 2004; 292 (21): 2643-6
19. Hasford J, Goettler M, Munter KH, et al. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002; 55: 945-50
20. Herdeiro MT, Figueiras A, Polonia J, et al. Physicians' attitudes and adverse drug reaction reporting a casecontrol study in Portugal. Drug Saf 2005; 28 (9): 825-33
21. Vallano A, Cereza G, Pedros C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol 2005; 60 (6): 653-8
22. Trifiro G, Calogero G, Ippolito FM, et al. Adverse drug events in emergency department population: a prospective Italian study. Pharmacoepidemiol Drug Saf 2005; 14: 333-40
23. Bä ckström M, Mjö rndal T, Dahlqvist R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 2004; 13: 483-7
24. Cosentino M, Leoni O, Banfi F, et al. Attitudes to adverse drug reaction reporting by medical practitioners in a northern Italian district. Pharmacol Res 1997; 35 (2): 85-8
25. Figueiras A, Tato F, Fontainas J, et al. Influence of physicians' attitudes on reporting adverse drug events: a casecontrol study. Med Care 1999; 37 (8): 809-14
26. Atuah Kwame N, Dyfrig H, Munir P. Special safety considerations in drug development and pharmacovigilance. Drug Saf 2004; 27 (8): 535-54
27. Yee WP, Norton LL, Catania HF, et al. Developing a comprehensive medical reaction reporting system. Hosp Pharm 1995; 30: 384-96
28. Bates DW, Evans RS, Muref H, et al. Detecting adverse events using information technology. J Am Informat Assoc 2003; 10 (2): 115-28
29. Classen DC, Prestonick SL, Evans RS, et al. Description of a computer adverse drug event monitor using a hospital information system. Hosp Pharm 1992; 27: 774-83
30. Herdeiro MT, Polonia J, Gestal-Otero JJ, et al. Improving the reporting of adverse drug reactions: a clusterrandomized trial among pharmacists in Portugal. Drug Saf 2008; 31 (4): 335-44
31. Figueiras A, Herdeiro MT, Polo' nia J, et al. Educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006; 296: 1086-93
32. Green CF, Mottram DR, Rowe PH, et al. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001; 51: 81-6
33. Sweis D, Wong ICK. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf 2000; 23 (2): 165-72
34. Green CF, Mottram DR, Brown AM, et al., Attitudes and knowledge of hospital pharmacists to adverse drug reactions and the ''yellow card'' scheme: a qualitative study. Int J Pharm Pract 1999; 7: 247-55
35. Herdeiro MT, Figueiras A, Polo' nia J, et al. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2006; 29 (4): 331-40
36. Bussières JF, Blond M, Lebel D, et al. Inte' gration de la pharmacovigilance à la pratique clinique. J Pharm Clin 2006; 25 (2): 1-8
37. Health Canada. MedEffect Canada: adverse reaction reporting [online]. Available from URL: http://www.hc-sc. gc.ca/dhp-mps/medeff/report-declaration/ who-qui-eng. php#a2 [Accessed 2009 May 6]
38. Miles MB, Huberman M. Qualitative data analysis: an expanded sourcebook. 2nd ed. London: Sage, 1994
39. Denzin NK, Lincoln YS. The Sage handbook of qualitative research. 3rd ed. London: Sage, 2005
40. Pires AP, E' chantillonnage et recherche qualitative. In: Poupart J, Deslauriers JP, Groulx LH, et al. editors. La recherche qualitative: enjeux e' piste' mologiques et me' thodologiques. Montre' al: Gae' tan Morin, 1997: 113-69
41. Poupart J, Deslauriers JP, Groulx LH, et al. La recherche qualitative: enjeux e' piste' mologiques et me' thodologiques. Montre' al: Gae' tan Morin, 1997
42. Health Canada. MedEffect Canada: adverse reaction reporting [online]. Available from URL: http://www.hc-sc. gc.ca/dhp-mps/medeff/report-declaration/ index-eng.php [Accessed 2008 Jun 7]
43. Giddens A. The consequences of modernity. Cambridge: Polity, 1990
44. Freidson E. Profession of medicine: a study of the sociology of applied knowledge. New York: Harper & Row, 1970
45. Beck U. Risk society: towards a new modernity. London: Sage, 1992
46. Biriell C, Edwards IR. Reasons for reporting adverse drug reactions: some thoughts based on an international review. Pharmacoepidemiol Drug Saf 1997; 6: 21-6